October 2024

South Africa's HIV prevention pill programme leads globally with 1.65M users by August 2024, aiming to reduce new infections and meet UNAIDS targets by 2025.

New studies confirm the effectiveness of a six-month HIV prevention injection, showing remarkable results in reducing infections across diverse populations.

Unpacking the governance crisis at Bonitas Medical Fund - concerns rise over trustees' decisions and potential conflicts of interest.

Lessons from the COVID-19 pandemic can guide South Africa's National Health Insurance (NHI) towards achieving health equity for all citizens.

Health Minister Aaron Motsoaledi addresses the shortfall in community service posts for medical graduates by converting surplus posts in other healthcare areas.

Learn how transforming vaccine manufacture in Africa aims to enhance self-sufficiency and ensure better healthcare access for all.

Pepfar head John Nkengasong urges US Congress to return to a five-year reauthorisation of HIV/AIDS relief funding for countries like South Africa.

Eli Lilly is betting on weight-loss drugs like Mounjaro, but can it overcome production challenges to become the first trillion-dollar pharmaceutical company?

COVID vaccination rates remain low, with less than 5% of US adults receiving the latest shot. Convenience and cost are impacting uptake and potential solutions.

As World Mental Health Day approaches, survey underscores urgent need for better mental health support in South African workplaces.

Explore the impact of AI and collaborative partnerships in advancing cancer care, reducing the burden of this relentless disease on families and communities.